Stock listing

LSE:EKF EKF Diagnostics Holdings plc Share Price

Home listing (LSE) of EKF Diagnostics Holdings plc

Follow EKF Diagnostics Holdings plc into a list and get an email when it puts out news.

Share price · LSE:EKF

24.00p GBX (pence) +0.60 (+2.6%)

Close on Nov 20, 2026

Past year -3.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
23.50p – 24.00p GBX (pence)Nov 20, 2026
Volume
50,738 sharesNov 20, 2026
Market cap
£102.7M GBPAt the close on Nov 20, 2026 · price × 428.0M shares outstanding
52-week range
21.80p – 29.00p GBX (pence)Lowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
£89,694 GBPMedian day 121,719 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
EKF Diagnostics Holdings plc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
LSE:EKF · Home24.00p GBX (pence)+0.60 (+2.6%)50,73824.00p24.00p23.50p23.40pClose on Nov 20, 2026
Frankfurt:LYF€0.27 EUR+0.006 (+2.3%)—€0.268€0.27€0.268€0.264Close on Nov 20, 2026
OTC:EKDHF$0.329 USD0.000 (0.0%)—$0.329$0.329$0.329$0.329Close on Nov 6, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · LSE:EKF · GBX (pence), adjusted for splits

DayCloseChange%OpenHighLowVolume
24.00p+0.60+2.6%24.00p24.00p23.50p50,738
23.40p-0.30-1.3%23.90p23.90p23.33p109,545
23.70p-0.20-0.8%23.70p23.93p23.50p84,597
23.90p-0.10-0.4%24.40p24.60p23.90p106,244
24.00p-0.40-1.6%24.40p24.40p24.00p365,715
24.40p+0.15+0.6%24.60p24.70p24.17p63,895
24.25p-0.15-0.6%24.60p24.64p24.20p58,183
24.40p0.000.0%25.00p25.12p24.40p31,731
24.40p0.000.0%24.40p24.92p24.40p199,362
24.40p-0.90-3.6%24.40p25.00p24.40p156,895
25.30p+1.70+7.2%23.60p25.30p23.50p434,402
23.60p+0.20+0.9%24.00p24.00p23.10p244,745
23.40p-0.10-0.4%23.00p24.40p23.00p86,187
23.50p-0.50-2.1%23.10p23.80p23.00p265,282
24.00p+0.25+1.1%23.90p24.00p23.45p64,501
23.75p+0.45+1.9%24.40p24.40p23.44p551,583
23.30p-1.10-4.5%24.30p24.90p23.20p491,187
24.40p-0.40-1.6%24.00p24.80p24.00p203,990
24.80p+0.50+2.1%24.40p24.80p23.85p117,858
24.30p0.000.0%23.60p24.59p23.60p11,434
24.30p+0.05+0.2%24.40p24.40p24.00p62,711
24.25p-0.45-1.8%24.20p24.81p24.08p87,971
24.70p-0.30-1.2%24.70p24.90p24.16p55,401
25.00p0.000.0%25.90p25.90p24.40p104,665
25.00p+0.40+1.6%24.10p25.00p24.10p67,478
24.60p+0.60+2.5%24.10p25.50p24.08p200,579
24.00p-1.50-5.9%24.90p25.40p24.00p131,005
25.50p-0.50-1.9%25.60p26.00p25.19p99,876
26.00p0.000.0%25.90p26.00p24.90p121,719
26.00p+1.80+7.4%25.40p26.00p24.80p263,027
24.20p+0.20+0.8%24.10p25.18p24.00p328,398
24.00p0.000.0%24.00p24.60p24.00p53,091
24.00p-0.10-0.4%24.00p24.60p24.00p82,116
24.10p-0.50-2.0%24.70p25.50p24.10p43,261
24.60p-0.10-0.4%24.20p24.60p24.20p14,337
24.70p+0.10+0.4%24.70p25.40p24.30p9,401
24.60p-0.30-1.2%24.30p25.10p24.30p62,589
24.90p+0.25+1.0%24.90p25.00p24.36p183,968
24.65p+0.25+1.0%24.80p25.40p24.58p308,983
24.40p-1.45-5.6%25.00p26.60p24.30p923,245
25.85p+0.20+0.8%26.60p26.70p25.00p120,776
25.65p+0.65+2.6%25.60p26.60p25.14p203,275
25.00p0.000.0%25.60p26.70p25.00p1,853,982
25.00p-1.00-3.8%26.60p26.70p25.00p207,114
26.00p+0.30+1.2%25.00p26.70p25.00p7,569,254
25.70p+0.70+2.8%25.10p26.00p25.10p355,551
25.00p-0.60-2.3%25.70p25.70p25.00p191,988
25.60p-0.40-1.5%25.70p26.13p25.51p2,632,661
26.00p+0.50+2.0%25.30p26.00p25.27p137,453
25.50p-0.10-0.4%25.20p25.50p25.20p161,238
25.60p+0.20+0.8%25.60p25.60p25.01p77,735
25.40p+0.25+1.0%25.60p25.60p24.90p78,800
25.15p-0.10-0.4%25.60p25.60p25.00p102,897
25.25p0.000.0%25.40p25.60p24.40p92,289
25.25p-0.05-0.2%25.00p25.40p24.50p208,826
25.30p0.000.0%24.80p25.30p24.54p48,096
25.30p+0.30+1.2%24.50p25.40p24.50p184,416
25.00p-0.30-1.2%25.30p25.40p24.87p72,400
25.30p-0.10-0.4%25.40p25.40p24.78p159,721
25.40p+0.40+1.6%25.30p25.40p24.77p101,788
25.00p+0.30+1.2%25.00p25.40p24.70p661,076
24.70p-0.70-2.8%24.70p25.40p24.61p258,266
25.40p0.000.0%25.40p25.40p24.80p105,177
25.40p+0.40+1.6%25.30p25.40p24.70p216,049
25.00p-0.10-0.4%24.80p25.00p24.37p395,611
Ticker
LSE:EKF
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
LSE
Currency
GBX

What changed lately

Latest news

H1 2026 Trading Update

Jul 30, 2026

Closed 25.80p (-0.8%) on Jul 30, 2026

Long Term Incentive Plan Award

May 20, 2026

Closed 28.00p (+5.7%) on May 21, 2026

AGM statement & positive Q1 trading update

May 19, 2026

Closed 26.70p (-1.1%) on May 19, 2026

Board Changes

Apr 27, 2026

Closed 25.50p (+4.1%) on Apr 27, 2026

Posting of Annual Report & Notice of AGM

Apr 24, 2026

Closed 25.50p (+4.1%) on Apr 27, 2026

Acquisition of assets from Beep Insights

Apr 13, 2026

Closed 24.00p (-0.8%) on Apr 13, 2026

Share Buyback

Apr 10, 2026

Closed 24.20p (+0.2%) on Apr 10, 2026

Full year results

Mar 24, 2026

Closed 24.40p (-0.8%) on Mar 24, 2026

Holding(s) in Company

Mar 19, 2026

Closed 24.30p (-0.4%) on Mar 19, 2026

Notice of Results

Mar 5, 2026

Closed 26.05p (-3.5%) on Mar 5, 2026

All EKF Diagnostics Holdings plc news

EKF Diagnostics Holdings plc on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 283 in all · newest Jul 30, 2026 · oldest 2003
Calls
13 calls with a replay · 13 with a transcript · latest Sep 15, 2026
Decks
30 decks · latest Sep 15, 2026

Where EKF Diagnostics Holdings plc is listed

ListingExchangeCountryCurrency
LSE:EKF · Home listing · This pageLSEUnited KingdomGBX
Frankfurt:LYFFrankfurtGermanyEUR
OTC:EKDHFOTCUnited StatesUSD
LS Exchange:622434LS ExchangeGermanyEUR
Lang & Schwarz:622434Lang & SchwarzGermanyEUR
Aquis:EKFLAquisUnited KingdomGBX
Stuttgart:LYFStuttgartGermanyEUR
AQUIS:EKF.GBAQUISUnited KingdomGBX
Turquoise:EKFLTurquoiseUnited KingdomGBX

Valuation

P/E 48.4× against a median of 13.4×: 5th lowest of 6 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
£88.21M GBP
P/E
48.4×
EV/sales
1.7×
EV/EBITDA
7.1×
Price/book
1.5×
Gross margin
51.3%
Operating margin
13.5%
Net margin
4.1%
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
EKF Diagnostics Holdings plc · LSE:EKFUS$134.4MUS$115.4M48.4×1.7×7.1×1.5×4.1%0.0×n/a
Boditech Med, Inc. · KRX:206640US$152.0MUS$120.9M7.9×0.9×4.4×0.8×14.8%0.0×n/a
Genovis AB · OMXSTO:GENOUS$150.3MUS$142.9M74.9×10.8×41.7×5.0×15.1%0.3×n/a
Genomictree, Inc. · KRX:228760US$147.7MUS$88.88Mn/a40.6×n/a1.6×−306.4%0.0×n/a
Anbio Biotechnology · NASDAQ:NNNNUS$145.7MUS$133.8M22.8×15.5×n/a4.8×74.1%0.0×0.56
MaxCyte, Inc. · NASDAQ:MXCTUS$141.5MUS$57.06Mn/a1.7×n/a0.9×−81.4%0.1×0.93
Shanghai Rightongene Biotechnology Co. Ltd. Class A · SSE:688217US$139.3MUS$102.6Mn/a4.6×n/a1.1×−43.9%0.0×n/a
Bioventix PLC · LSE:BVXPUS$133.3MUS$126.3M13.4×7.4×9.7×9.2×57.8%0.0×n/a
Curiosis, Inc. · KRX:494120US$131.1MUS$117.6Mn/a18.7×n/a7.1×−93.3%0.0×n/a
Bioneer Corporation · KRX:064550US$127.6MUS$107.1Mn/a0.4×10.0×0.8×−1.9%0.3×n/a
Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FFUS$123.5MUS$174.6M11.1×0.6×4.6×0.8×4.0%0.6×n/a
Median of the othersUS$140.4MUS$119.3M13.4×6.0×9.7×1.4×1.0%0.0×0.75

Forecasts

Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
34.67 GBX · Analysts' mean
EPS, year to Dec 2026
0.017 · 3 analysts
Revenue, year to Dec 2026
54.56M · 3 analysts

Team and board

Officers

OfficerRole
Gavin JonesChief Executive Officer
Helen JonesChief Financial Officer
Julian BainesExecutive Chairman

Board

DirectorRole
Julian BainesExecutive Chairman
Christian RiggSenior Independent Non-Executive Director
Christopher MillsNon-Executive Director
Gavin JonesChief Executive Officer
Helen JonesChief Financial Officer
Jenny WinterNon-Executive Director

Events

Calls

CallWhenStatus
EKF Diagnostics Holdings (LSE:EKF) Q2 2026 Earnings CallTue, Sep 15, 2026 · 11:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Interim results for the six months ended 30 June 2026Tue, Sep 15, 2026 · 11:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Preliminary ResultsTue, Mar 24, 2026 · 7:00 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) Q2 2025 Earnings CallTue, Sep 16, 2025 · 5:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Full year results for the year ended 31 December 2024Tue, Mar 25, 2025 · 12:15 PM ETReplay
EKF Diagnostics Holdings (LSE:EKF) Q4 2024 Earnings CallTue, Mar 25, 2025 · 5:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Interim ResultsWed, Sep 18, 2024 · 11:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Full Year ResultsWed, Mar 20, 2024 · 11:00 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Interim resultsTue, Sep 26, 2023 · 12:30 PM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Preliminary ResultsTue, Mar 28, 2023 · 11:30 AM ETReplay
All 13 calls
CallWhenStatus
EKF Diagnostics Holdings (LSE:EKF) — Half-year ResultsTue, Sep 20, 2022 · 11:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Preliminary ResultsTue, Mar 29, 2022 · 11:30 AM ETReplay
EKF Diagnostics Holdings (LSE:EKF) — Interim results for the six months ended 30 June 2020Mon, Sep 14, 2020 · 11:30 AM ETReplay

Results days

QuarterResultsShare move
Q2 2025Sep 15, 2025 · Before open−1.0%
Quarter to Mar 31, 2025Apr 24, 2025−1.9%
Q4 2022Mar 28, 2023 · After close+12.7%
Q2 2022Sep 20, 2022 · After close+1.0%
Q4 2021Mar 29, 2022 · Before open−13.7%
Q2 2021Sep 14, 2021+3.8%
Q4 2020Mar 22, 2021+3.1%

Open Events

Decks

DeckKindSlidesDate
H1 2026 Earnings PresentationEarnings31 slidesSep 15, 2026
FY2025 Earnings PresentationEarnings37 slidesMarch 2026
Q2 2025 Earnings PresentationEarnings20 slidesSep 16, 2025
FY2024 Earnings PresentationEarnings25 slidesMar 25, 2025
H1 2024 Earnings PresentationEarnings28 slidesSeptember 2024
FY2023 Earnings PresentationEarnings33 slides2024
H1 2023 Earnings PresentationEarnings20 slidesSeptember 2023
FY2022 Earnings PresentationEarnings27 slidesMarch 2023
H1 2022 Earnings PresentationEarnings27 slidesSeptember 2022
FY2021 Earnings PresentationEarnings24 slidesMarch 2022
All 30 decks
DeckKindSlidesDate
H1 2021 Earnings PresentationEarnings21 slidesSep 14, 2021
Investor Presentation (June 2021)Investor deck15 slidesJun 7, 2021
Investor Presentation (April 2021)Investor deck20 slidesApril 2021
FY2020 Earnings PresentationEarnings20 slidesMar 30, 2021
H1 2020 Earnings PresentationEarnings20 slidesSep 14, 2020
FY2019 Earnings PresentationEarnings15 slidesMar 24, 2020
H1 2019 Earnings PresentationEarnings22 slidesSeptember 2019
FY2018 Earnings PresentationEarnings24 slidesMar 13, 2019
Renalytix AI — IPO Roadshow (October 2018)IPO roadshow23 slidesOctober 2018
H1 2018 Earnings PresentationEarnings9 slidesSep 19, 2018
FY2017 Earnings PresentationEarnings23 slidesMar 14, 2018
H1 2017 Earnings PresentationEarnings18 slidesSep 11, 2017
FY2016 Earnings PresentationEarnings24 slidesMar 21, 2017
H1 2016 Earnings PresentationEarnings19 slidesSep 12, 2016
FY2015 Earnings PresentationEarnings29 slidesApr 12, 2016
Investor Presentation (March 2016)Investor deck31 slidesMarch 2016
FY2014 Earnings PresentationEarnings35 slidesMar 16, 2015
H1 2014 Earnings PresentationEarnings32 slidesSep 15, 2014
FY2013 Earnings PresentationEarnings31 slidesFeb 26, 2014
H1 2013 Earnings PresentationEarnings30 slidesSep 16, 2013

Open Decks

Financials

Annual, in GBP

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue51.6M50.2M52.6M66.6M81.8M65.3M44.9M42.5M41.6M38.6M
Cost of revenue25.1M28.7M28.8M42.6M42.5M27.8M21.2M19.8M18.7M20.3M
Gross profit26.5M21.5M23.9M24.0M39.4M37.4M23.7M22.7M22.9M18.3M
Research and development1.44M1.34M1.82M1.52M1.38M1.44M2.27M1.64M2.20M2.04M
Selling, general and administrative19.7M18.1M19.7M23.2M17.7M20.7M18.3M10.6M18.2M18.7M
Operating income6.98M6.46M2.08M7.56M21.7M16.9M5.78M12.2M4.73M-327.0K
Depreciation and amortization5.40M4.72M5.47M6.66M5.88M4.61M4.44M3.99M4.62M4.96M
EBITDA12.4M11.2M7.55M14.2M27.6M21.5M10.2M16.2M9.35M4.63M
Interest expense154.0K171.0K75.0K102.0K68.0K76.0K339.0K35.0K106.0K505.0K
Income before tax7.09M6.26M2.13M-8.94M21.4M15.4M5.52M12.2M4.31M-1.00M
Income tax4.55M-314.0K-600.0K634.0K5.28M3.97M1.59M1.87M1.37M-1.17M
Net income2.12M6.24M2.35M-10.1M15.9M11.1M3.68M10.1M2.71M-18.0K
Earnings per share, basic0.000.010.01-0.020.030.020.010.020.01-0.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents15.8M14.3M6.02M11.6M20.3M21.9M12.1M10.3M8.20M7.87M
Short-term investments-1.29M
Receivables6.04M6.28M6.23M8.59M11.7M12.7M7.62M7.14M7.12M9.16M
Inventory8.30M7.39M8.77M9.43M13.2M8.49M6.07M6.12M5.64M6.03M
Current assets30.9M28.6M25.6M31.8M47.6M44.0M26.2M23.8M21.3M23.3M
Property, plant and equipment21.7M17.9M13.6M13.2M12.5M12.1M12.1M
Goodwill24.1M23.9M24.4M25.1M27.4M24.4M23.8M24.9M24.4M24.8M
Total assets81.1M81.7M80.8M89.3M115.1M101.3M87.1M81.4M77.2M82.4M
Accounts payable747.0K900.0K984.0K1.50M4.43M2.41M748.0K1.23M1.49M1.20M
Current liabilities7.42M6.44M9.50M11.7M13.7M19.4M12.9M13.6M12.3M16.6M
Long-term debt000431.0K323.0K480.0K695.0K872.0K1.13M
Total debt1.39M1.32M4.10M1.55M3.47M1.96M1.66M880.0K1.21M5.72M
Total liabilities10.9M8.53M12.6M14.8M20.4M23.1M16.0M17.5M16.7M21.5M
Shareholders' equity69.0M72.3M67.1M73.3M94.1M77.6M70.6M63.5M60.0M60.5M
Shares outstanding448.5M453.7M454.1M457.2M461.0M458.8M458.4M461.5M469.3M450.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations9.71M13.7M6.31M9.69M10.2M13.8M5.10M8.32M9.05M8.94M
Capital spending-1.53M-2.25M-6.97M-5.83M-5.65M-2.65M-2.38M-1.85M-2.21M-1.92M
Free cash flow8.18M11.4M-664.0K3.86M4.59M11.2M2.73M6.47M6.84M7.02M
Cash from investing-2.34M-2.66M-5.64M-8.93M-5.48M1.34M-2.40M-4.93M-2.03M-1.43M
Cash from financing-5.86M-4.08M-3.65M-11.0M-6.16M-5.21M-634.0K-1.49M-6.42M-2.11M
Dividends paid-5.45M-5.46M-5.10M-4.55M-15.0K-4.55M-4.55M
Share buybacks-4.99M00-3.90M0-7.00K-15.0K-940.0K-241.0K4.54M
Change in cash1.53M6.58M-3.85M-8.76M-1.57M9.84M1.79M2.08M329.0K5.86M

Open Financials

Cap table

Built by 6ix from EKF Diagnostics Holdings plc’s releases

Common shares
427,968,392
Fully diluted
427,968,392

Fully diluted

LineShares
Common shares427,968,392

Share count over time

CountShares
Nov 22, 2026427,968,392

Open Cap table

Shareholders

HolderSharesValueChangeAs of
iShares International Small-Cap Equity Factor ETF529KUS$183K+10,715Jul 31, 2026
International Sustainability Core 1 Portfolio91,050US$31,409No changeJul 31, 2026
The United Kingdom Small Company Series79,384US$27,384No changeJul 31, 2026
Dimensional VA International Small Portfolio40,219US$13,874No changeJul 31, 2026
Brighthouse/Dimensional International Small Company Portfolio38,020US$13,607No changeJun 30, 2026
First American Multi-Manager International Equity Fund33,466US$11,977NewJun 30, 2026
World ex U.S. Core Equity Portfolio10,269US$3,542No changeJul 31, 2026
International Small Company Trust8,242US$2,954No changeJun 30, 2026
LVIP Dimensional International Core Equity Fund5,002US$1,791No changeJun 30, 2026
International Social Core Equity Portfolio4,462US$1,539No changeJul 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christian RiggSenior Independent Non-Executive Director · Since at least Mar 26, 2025
Christopher MillsNon-Executive Director · Since at least Apr 24, 2026
Gavin JonesChief Executive Officer · Since at least Mar 25, 2025
Helen JonesChief Financial Officer · Since at least Apr 27, 2026
Jenny WinterNon-Executive Director · Since at least May 20, 2026
Julian BainesExecutive Chairman · Since at least Jul 30, 2026

Open People

Log in to ask 6ix AI your own questions about EKF Diagnostics Holdings plc.